On Tuesday, Tango Therapeutics Inc (NASDAQ: TNGX) opened higher 8.53% from the last session, before settling in for the closing price of $8.91. Price fluctuations for TNGX have ranged from $1.03 to $11.20 over the past 52 weeks.
A company in the Healthcare sector has jumped its sales by 7.47% annually for the last half of the decade. Company’s average yearly earnings per share was noted 26.81% at the time writing. With a float of $88.66 million, this company’s outstanding shares have now reached $111.57 million.
Tango Therapeutics Inc (TNGX) Insider Updates
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Tango Therapeutics Inc is 34.17%, while institutional ownership is 73.13%. The most recent insider transaction that took place on Oct 23 ’25, was worth 4,846,575. In this transaction 10% Owner of this company sold 477,401 shares at a rate of $10.15, taking the stock ownership to the 13,386,574 shares. Before that another transaction happened on Oct 23 ’25, when Company’s 10% Owner proposed sale 477,401 for $7.53, making the entire transaction worth $3,594,830.
Tango Therapeutics Inc (TNGX) Performance Highlights and Predictions
If we go through the results of last quarter, which was made public on 12/31/2024, the company posted -0.34 earnings per share (EPS) for the quarter, besting the agreed prediction (set at -0.34) by 0. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.31 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 26.81% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -4.76% during the next five years compared to 7.47% growth over the previous five years of trading.
Tango Therapeutics Inc (NASDAQ: TNGX) Trading Performance Indicators
Check out the current performance indicators for Tango Therapeutics Inc (TNGX). In the past quarter, the stock posted a quick ratio of 8.88. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 19.58.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.92, a number that is poised to hit -0.32 in the next quarter and is forecasted to reach -1.25 in one year’s time.
Technical Analysis of Tango Therapeutics Inc (TNGX)
Let’s dig in a bit further. During the last 5-days, its volume was 2.55 million. That was better than the volume of 1.66 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 80.92%.
During the past 100 days, Tango Therapeutics Inc’s (TNGX) raw stochastic average was set at 69.09%, which indicates a significant decrease from 98.56% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.49 in the past 14 days, which was lower than the 0.58 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $8.80, while its 200-day Moving Average is $5.88. However, in the short run, Tango Therapeutics Inc’s stock first resistance to watch stands at $9.94. Second resistance stands at $10.22. The third major resistance level sits at $10.74. If the price goes on to break the first support level at $9.14, it is likely to go to the next support level at $8.62. Assuming the price breaks the second support level, the third support level stands at $8.34.
Tango Therapeutics Inc (NASDAQ: TNGX) Key Stats
There are currently 134,677K shares outstanding in the company with a market cap of 1.30 billion. Presently, the company’s annual sales total 42,070 K according to its annual income of -130,300 K. Last quarter, the company’s sales amounted to 53,810 K and its income totaled 15,880 K.
